< Back to previous page
Patent
Fused bicyclic heteroaromatic derivatives as kinase inhibitors
A series of fused bicyclic heteroaromatic derivatives of formula (IA) or (IB), as defined herein, being selective inhibitors of phosphatidylinositol-4-kinase IIIβ (PI4KIIIβ) activity, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and organ and cell transplant rejection.
Patent Publication Number: US9969748
Year filing: 2018
Year approval: 2018
Year publication: 2018
Status: Assigned
URI: link to Espacenet
Technology domains: Pharmaceuticals, Basic materials chemistry
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven